Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine
- 16 July 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 320 (1) , 90-94
- https://doi.org/10.1016/j.bbrc.2004.05.142
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Transporters and Renal Drug EliminationAnnual Review of Pharmacology and Toxicology, 2004
- Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drugPublished by Wiley ,2003
- The Anti-Influenza Drug Oseltamivir Exhibits Low Potential to Induce Pharmacokinetic Drug Interactions via Renal Secretion—Correlation of in Vivo and in Vitro StudiesDrug Metabolism and Disposition, 2002
- Structure, function, and genomic organization of human Na+-dependent high-affinity dicarboxylate transporterAmerican Journal of Physiology-Cell Physiology, 2000
- The Antiviral Nucleotide Analogs Cidofovir and Adefovir Are Novel Substrates for Human and Rat Renal Organic Anion Transporter 1Molecular Pharmacology, 1999
- Molecular Cloning and Characterization of Two Novel Human Renal Organic Anion Transporters (hOAT1 and hOAT3)Biochemical and Biophysical Research Communications, 1999
- Molecular cloning and functional expression of a multispecific organic anion transporter from human kidneyAmerican Journal of Physiology-Renal Physiology, 1999
- Cloning of a Human Renal p–Aminohippurate Transporter, hROAT1Kidney and Blood Pressure Research, 1998
- Pharmacological Rationale for the Clinical Use of CaffeineDrugs, 1995
- The use of caffeine for enzyme assays: A critical appraisalClinical Pharmacology & Therapeutics, 1993